Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUMM.L Share News (SUMM)

  • There is currently no data for SUMM

XP Power founder trims holding

Wed, 04th Aug 2010 16:28
XP Power deputy chairman James Peters raised £1.47m from a share disposal two days after bumper interim figures from the power control products supplier. Peters sold 200,000 shares at 735p each. Peters founded XP in 1988 and still owns nearly 2.7m shares, which is equivalent to 14%. That still makes him the biggest shareholder in XP. It was announced yesterday evening that finance director Mickey Lynch had sold 25,000 shares at 730.21p a share. That raised nearly £183,000 and left Lynch with 81,000 shares. Lynch bought 3,500 shares at 372p each and 2,500 shares at 362p each last November. That indicates how strong the XP share price has been in recent months. The share price is more than five times the level it was at the beginning of 2009. XP nearly doubled its pre-tax profit from £3.8m to £7.3m in the six months to June 2010. Revenues were 23% higher at £40.7m and they should continue to improve in the second half. XP Power has record order books.Edison Investment Research says that a higher proportion of own-designed/own-manufactured products has enabled XP to increase its margins. XP is using around 50% of its Chinese capacity and it is planning a factory in Vietnam, which should be in production before the end of 2011. Edison upgraded its 2010 earnings per share forecast by 13% to 62p. That means that the shares are trading on less than 12 times prospective earnings for 2010. Top Director BuysCapital & Counties Properties (CAPC) Director name: Mr Gary YardleyAmount purchased: 88,579 @ 112.05p Value: £99,253Capital & Counties Properties (CAPC) Director name: Mr Ian DurantAmount purchased: 64,024 @ 112.05p Value: £71,739Mid Wynd International Inv Trust (MWY) Director name: Mr Russell Napier Amount purchased: 5,200 @ 960.00p Value: £49,920Filtronic (FTC) Director name: Mr Edwin Graham MeekAmount purchased: 50,000 @ 38.00p Value: £19,000Filtronic (FTC) Director name: Mr Howard FordAmount purchased: 42,204 @ 35.00p Value: £14,771Summit Corporation (SUMM) Director name: Mr Raymond SpencerAmount purchased: 400,000 @ 2.93p Value: £11,720Severn Trent (SVT) Director name: Mr Gordon FryettAmount purchased: 1,000 @ 1,141.00p Value: £11,410Top Director SellsXP Power (XPP) Director name: Mr James E PetersAmount sold: 200,000 @ 735.00p Value: £1,470,000BT Group (BT.A) Director name: Mr Ian LivingstonAmount sold: 72,725 @ 141.99p Value: £103,262BT Group (BT.A) Director name: Mr Tony ChanmugamAmount sold: 19,635 @ 141.99p Value: £27,880

Related News

Odyssean says return beats market despite "another volatile period"
4 days ago

Odyssean says return beats market despite "another volatile period"

(Alliance News) - Odyssean Investment Trust PLC on Wednesday reported double-digit net asset value growth for its latest financial year.

LONDON MARKET CLOSE: Financials lift FTSE 100 as oil heads below USD80
5 days ago

LONDON MARKET CLOSE: Financials lift FTSE 100 as oil heads below USD80

(Alliance News) - The FTSE 100 made strong progress on Tuesday as oil fell further amid growing confidence in the US-Iran peace process.

IN BRIEF: Essentra hires former BBC executive as senior director
5 days ago

IN BRIEF: Essentra hires former BBC executive as senior director

Essentra PLC - Oxford, England-based manufacturer and distributor of plastic-injection-moulded, vinyl-dip-moulded and metal components - Hires Sharmil...

SUMM.L News

Summit Therapeutics Delists In London As Focus Shifts To US
24 Feb 2020

Summit Therapeutics Delists In London As Focus Shifts To US

Summit Therapeutics Delists In London As Focus Shifts To US

Summit Therapeutics Chief Operating & Medical Officer Roblin Resigns
24 Jan 2020

Summit Therapeutics Chief Operating & Medical Officer Roblin Resigns

Summit Therapeutics Chief Operating & Medical Officer Roblin Resigns

Summit Gets More Funding For C. Difficile Infection Treatment
23 Jan 2020

Summit Gets More Funding For C. Difficile Infection Treatment

Summit Gets More Funding For C. Difficile Infection Treatment

Summit Therapeutics Shuffles Board After Raising USD50 Million
24 Dec 2019

Summit Therapeutics Shuffles Board After Raising USD50 Million

Summit Therapeutics Shuffles Board After Raising USD50 Million

Summit Therapeutics raises $40m, completes board restructuring
24 Dec 2019

Summit Therapeutics raises $40m, completes board restructuring

(Sharecast News) - Antibiotic innovation company Summit Therapeutics raised $50.0m on Tuesday by way of a subscription and placing of new ordinary sha...

Summit Therapeutics Reports Decrease In Revenue In Third Quarter
17 Dec 2019

Summit Therapeutics Reports Decrease In Revenue In Third Quarter

Summit Therapeutics Reports Decrease In Revenue In Third Quarter

Summit Therapeutics Plans Wholesale Changes As It Raises Cash
6 Dec 2019

Summit Therapeutics Plans Wholesale Changes As It Raises Cash

Summit Therapeutics Plans Wholesale Changes As It Raises Cash

Summit Therapeutics raising $50m, plans to delist from AIM
6 Dec 2019

Summit Therapeutics raising $50m, plans to delist from AIM

(Sharecast News) - Antibiotic innovation company Summit Therapeutics announced a proposed fundraising of about $50m through a subscription and placing...